Molecular Immunology

Special Issues

Following special issues within this section are currently open for submissions:

• Crosstalk between Epigenetic and Metabolic Mechanisms in Chronic Inflammation (Deadline: 10 December 2021)
• New Insights in Cancer Drug Resistance Mechanisms and Targeted Therapies (Deadline: 15 December 2021)
• Molecular Mechanisms of Immunothrombosis, Autoimmunity, and Development of Next Generation Anticoagulants (Deadline: 15 December 2021)
• Infection and the Kidney (Deadline: 16 December 2021)
• Immunological Investigations in Hematology (Deadline: 17 December 2021)
• Regulation of mTOR Signaling in Various Organisms (Deadline: 24 December 2021)
• Cytokine Release Syndrome: From Cell Metabolism to Organ Dysfunction (Deadline: 30 December 2021)
• Hepatitis C Virus – Molecular Biology, Disease and Treatment (Section 1) 2.0 (Deadline: 31 December 2021)
• Mitochondrial Proteomics in Neuroscience and Neurodegenerative Disease (Deadline: 31 December 2021)
• Inflammasomes and Inflammation (Deadline: 31 December 2021)
• Infections and Pregnancy (Deadline: 31 December 2021)
• T-Regulatory Cells in Autoimmunity and Transplantation (Deadline: 31 December 2021)
• Advances and Perspectives in Epigenetics and Autoimmune Diseases (Deadline: 31 December 2021)
• Recent Research on Kallikreins (Deadline: 31 December 2021)
• Advances in Endothelial Cell Biology 2.0 (Deadline: 31 December 2021)
• Tumor Microenvironment and Immune Response (Deadline: 31 December 2021)
• Immune Response in Cystic Fibrosis: Interplay between the Host and Microbes (Deadline: 31 December 2021)
• Extracellular Heat Shock Proteins as Regulator of the Immune System (Deadline: 31 December 2021)
• Mesenchymal Stem Cells: Immunobiology and Role in Immunomodulation and Tissue Regeneration (Deadline: 31 December 2021)
• The Role of Progesterone in the Feto-Maternal Immunological Relationship (Deadline: 31 December 2021)
• Frontiers in Immuno-Oncology (Deadline: 31 December 2021)
• Host-Cytomegalovirus Interactions: Pro- and Antiviral Key Factors Affecting CMV Infection Outcome or Therapeutic Approaches 3.0 (Deadline: 31 December 2021)
• The Pathogenesis of Rheumatoid Arthritis—Breakthroughs in Molecular Mechanisms (Deadline: 31 December 2021)
• Mast Cells: From Host Defense to Pathology (Deadline: 31 December 2021)
• Immunological Nudging – Maintaining Vigilance and Reactivity (Deadline: 31 December 2021)
• Immunopathology of Atherosclerosis and Related Diseases: Focus on Molecular Biology 2.0 (Deadline: 31 December 2021)
• The Immune Checkpoint HLA-G (Deadline: 31 December 2021)
• Exploring the Multifunctional Roles of Host Defence RNases under Stress Conditions (Deadline: 31 December 2021)
• Gut Microbiota and Immunity 2.0 (Deadline: 31 December 2021)
• Novel Osteoarthritis Pathogenesis and Management (Deadline: 31 December 2021)
• Microglial Cells (Deadline: 31 December 2021)
• Tumor Immunology in Urogenital Cancers (Deadline: 10 January 2022)
• Pathophysiology of AKI from Sepsis to SARS-CoV-2 Infection: Molecular Basis, Diagnosis and Treatment (Deadline: 31 January 2022)
• Recent Research on Eosinophils (Deadline: 31 January 2022)
• Molecular and Biochemical Aspects in Burns (Deadline: 31 January 2022)
• Molecular and Cellular Mechanisms Underlying Probiotic Activity (Deadline: 31 January 2022)
• Neutrophils in Chronic Inflammation (Deadline: 31 January 2022)
• Biomaterials, Neuroimmunology and Stem Cells for Repair Strategies in the Central Nervous System (Deadline: 31 January 2022)
• Immunophenotyping in Autoimmune Diseases and Cancer 2.0 (Deadline: 31 January 2022)
• Plasmacytoid Dendritic Cells Involvement in Neuroimmune Disease (Deadline: 31 January 2022)
• Old and New Players in Inflammatory Disorders—in Memory of Dr. Nadia Ferlazzo (Deadline: 31 January 2022)
• Lipid Molecules in Inflammation and Chronic Diseases (Deadline: 31 January 2022)
• Interleukin 22 (Deadline: 31 January 2022)
• Immune Checkpoint Inhibitors and Immune Checkpoint Resistance (Deadline: 31 January 2022)
• Advances in Immunotherapeutic Approaches to Type 1 Diabetes 2.0 (Deadline: 31 January 2022)
• Evolution of, and Host Immunity to, Emergent Infectious Disease (Deadline: 31 January 2022)
• Roles of Erythrocytes in Human Health and Disease (Deadline: 31 January 2022)
• Manipulating Immune Tolerance with Cellular Therapies (Deadline: 31 January 2022)
• Neuroinflammation and Pain 2.0 (Deadline: 31 January 2022)
• Inflammation, Metabolism and Molecular Changes in Tissue Repair and Regeneration (Deadline: 10 February 2022)
• Glucans, Paramylon and other Algae Bioactive Molecules (Deadline: 15 February 2022)
• Proteomics for the Study of Inflammatory Diseases (Deadline: 25 February 2022)
• Molecular Basis and Cellular/Circuit Substrates of High Order Brain Functions in Physiology and Disease (Deadline: 28 February 2022)
• Immune Modulation and the Microbiome (Deadline: 28 February 2022)
• Musculoskeletal Disorders (MSDs) and Osteoimmunology (Deadline: 28 February 2022)
• Immunometabolism: From Molecular Mechanisms to Therapeutics (Deadline: 28 February 2022)
• The Many Facets of the Regulation of TCR Signaling (Deadline: 28 February 2022)
• Molecular Immunology in Hematological Disorders (Deadline: 28 February 2022)
• Innovative Targeted Therapies in Inflammatory Diseases (Deadline: 28 February 2022)
• Recent Advances in Immunonutrition (Deadline: 28 February 2022)
• Molecular Mechanisms Underlying the Improving Effects of Natural Compounds on Immune Cell Functions (Deadline: 28 February 2022)
• Challenges in Antigen Identification—HLA Peptides and TCR Receptors (Deadline: 28 February 2022)
• Inflammation versus Resolution: New Insights and Therapeutic Challenges in Atherosclerosis (Deadline: 28 February 2022)
• Role of NF-kappaB Pathway in Inflammation and Infection (Deadline: 28 February 2022)
• The Role and Modulation of Inflammation in Diseases (Deadline: 28 February 2022)
• Molecular Genetics and Pathogenesis of Atopic Dermatitis and Psoriasis (Deadline: 28 February 2022)
• Molecular Mechanisms of Endothelial Dysfunction (Deadline: 28 February 2022)
• Hematopoietic System under Physiological Conditions and Following Hematopoietic Reconstitution or Stress (Deadline: 28 February 2022)
• Inflammation and the Musculoskeletal System (Deadline: 28 February 2022)
• Phagocytosis: Current Understanding, Recent Developments, and Future Perspectives (Deadline: 28 February 2022)
• Immune Homeostasis and Regulation at the Surface of the Eye (Deadline: 5 March 2022)
• OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition (Deadline: 10 March 2022)
• Molecular Mechanisms of Major Inflammatory Occupational Diseases (Deadline: 30 March 2022)
• Molecular Basis and Advances of Targeted Immunotherapy for Cancer (Deadline: 31 March 2022)
• Apoptosis Studies in In Vivo/In Vitro Experimental Models of Non-ionizing Radiation (Deadline: 31 March 2022)
• Microenvironment and Nanocarriers (Deadline: 31 March 2022)
• Nutritional Immunity: Mechanisms, Host Effectors and Pathogen Bypass Strategies (Deadline: 31 March 2022)
• Antimicrobial Peptides and Immunology (Deadline: 31 March 2022)
• The Role of Nucleic Acids in Normal and Aberrant Immunity (Deadline: 31 March 2022)
• Macrophages in Immunotherapy (Deadline: 31 March 2022)
• Identification and Characterization of Genetic and Epigenomic Host Factors to Decipher Pathogenic Mechanisms Involved in Infectious Diseases (Deadline: 31 March 2022)
• Changes in Inhibitory Synapse Composition and Plasticity along the Progression of Neurodegenerative Diseases (Deadline: 31 March 2022)
• Innate Immune Cell Effector Responses (Deadline: 31 March 2022)
• Molecular Immunology of Solid Tumors (Deadline: 31 March 2022)
• Molecular Medicine in Asthma and Allergic Diseases (Deadline: 31 March 2022)
• Inflammation in the CNS and PNS: From Molecular Basis to Therapy (Deadline: 31 March 2022)
• Intercellular Communication in Cancer (Deadline: 31 March 2022)
• NK Cell Subsets in Health and Disease: New Developments (Deadline: 31 March 2022)
• Fibroblasts in Health and Disease (Deadline: 31 March 2022)
• Target Dysfunctional Inflammation in Cystic Fibrosis Airway 2.0 (Deadline: 31 March 2022)
• Advances in Multiple Sclerosis: Environmental Factors, Genetic, Immunotherapies and Immunopathogenesis (Deadline: 31 March 2022)
• The Research of Neutrophil (Deadline: 30 April 2022)
• Macrophage Polarization: Learning to Manage It (Deadline: 30 April 2022)
• Lipids in Neurodegenerative Diseases (Deadline: 30 April 2022)
• The Role of Vitamin D and/or the Cancer Phenotype in Shaping the Anti-neoplastic Immune System Response (Deadline: 30 April 2022)
• Immune Mediators and Disruptors of Neural Functions (Deadline: 30 April 2022)
• New Insights into Molecular Innate Immunity (Deadline: 30 April 2022)
• Centenarians—a Model to Study the Molecular Basis of Lifespan and Healthspan 2.0 (Deadline: 30 April 2022)
• Innate Lymphoid Cells: Cytokine-Mediated Communications (Deadline: 30 April 2022)
• Signaling and Organelle Polarization at the Immunological Synapse 2.0 (Deadline: 30 April 2022)
• Immune Pathogenesis and Regulation of Ocular Inflammation (Deadline: 30 April 2022)
• Evolving Perspectives in Colon Cancer Treatment and Research (Deadline: 30 April 2022)
• Reproductive Immunology: Cellular and Molecular Biology 2.0 (Deadline: 30 April 2022)
• Molecular Researches in Ophthalmology: Antibodies, Inflammation, Proteomics and Immune-Related Drug Development (Deadline: 30 April 2022)
• Novel Insights in Complications of Cellular Therapies (Deadline: 30 April 2022)
• Phenotypic and Functional Heterogeneity of Cells of the Monocytes/Macrophage Lineage (Deadline: 30 April 2022)
• Advances of Immuno-Oncology for Thoracic Cancers (Deadline: 30 April 2022)
• Interaction of Nanomaterials with the Immune System 2.0 (Deadline: 30 April 2022)
• The Twist and Turn of Lipids in Human Diseases (Deadline: 30 April 2022)
• Targeting Stromal Cell Signaling within the Tumor Microenvironment (Deadline: 30 April 2022)
• Virus–Host Interaction and Cell Restriction Mechanisms (Deadline: 30 April 2022)
• Molecular Biology of Allergens and Their Use in Allergy Diagnostics and Therapeutics (Deadline: 30 April 2022)
• Neuroinflammatory Processes in Organ Homeostasis and Disease (Deadline: 30 April 2022)
• Chronic Rhinosinusitis: Aetiology, Immunology and Treatment (Deadline: 30 April 2022)
• Natural Compounds for Inflammation and Anti-Inflammatory Mechanism (Deadline: 30 April 2022)
• State-of-the-Art Molecular Immunology in Spain (Deadline: 15 May 2022)
• State-of-the-Art Molecular Immunology in Italy (Deadline: 20 May 2022)
• Molecular Aspects of Inflammation in Pregnancy 2.0 (Deadline: 25 May 2022)
• Updates of Calcineurin/NFAT Signaling in Human Health and Diseases (Deadline: 26 May 2022)
• Amniotic Fluid and Placental Membranes as Sources of Stem Cells 2.0 (Deadline: 27 May 2022)
• Molecular Target and Action Mechanism of Anti-cancer Agents 2.0 (Deadline: 30 May 2022)
• Thyroid Autoimmunity and Autoimmune Hypothyroidism (Deadline: 31 May 2022)
• Fish Mucosal Physiology and Immunology 2.0 (Deadline: 31 May 2022)
• Inflammatory Skin Conditions 2022 (Deadline: 31 May 2022)
• Dendritic Cell and Cancer Therapy (Deadline: 31 May 2022)
• Cancer Immunotherapy Using Checkpoint Inhibitors: Future Directions 3.0 (Deadline: 31 May 2022)
• Metabolic Pathways in Immune Cells During Diseases (Deadline: 31 May 2022)
• Abiogenic Metal Cations: Friends or Foes in Host Immunity and Health (Deadline: 31 May 2022)
• Inflammatory Bowel Disease: From Pre-Clinial Models into Translation (Deadline: 31 May 2022)
• Unveil the Molecular Regulations of Immunological and Allergic Diseases (Deadline: 31 May 2022)
• Recent Advances in Immunotheragnostics: From Molecular Basis to Targeted Pharmaceutical Design (Deadline: 31 May 2022)
• Novel Findings in Immunity and Inflammation in Lung Injuries and Diseases (Deadline: 31 May 2022)
• Mechanisms of Innate Immune Activation and Regulation in Health and Disease (Deadline: 31 May 2022)
• Molecular and Cellular Mechanisms of Corneal Fibrosis/Scarring and Advances in Therapy (Deadline: 31 May 2022)
• Neutrophil in Cell Biology and Diseases (Deadline: 31 May 2022)
• Advances in Chronic Kidney Disease: An Update (Deadline: 24 June 2022)
• Aging: Oxidative Stress and Inflammation New Target for Promote Healthy Longevity (Deadline: 25 June 2022)
• SARS-CoV-2 Variants, Antibodies and Vaccines (Deadline: 25 June 2022)
• Hematopoietic and Lymphoid Tissue Involvement in Autoimmune Diseases (Deadline: 30 June 2022)
• Osteoimmunology in Rheumatic Diseases (Deadline: 30 June 2022)
• Effects of Chronic Inflammation on Brain Ageing and Sensory Decline (Deadline: 30 June 2022)
• Molecular Mechanisms Underlying Pituitary Pathogenesis (Deadline: 30 June 2022)
• Chemokine Receptor and Ligands on Pain and Itch (Deadline: 30 June 2022)
• The Stromal-Epithelial Dialogues in Health and Disease (Deadline: 30 June 2022)
• Tackle Lung Cancer by Means of Novel Immunotherapeutic Strategies (Deadline: 30 June 2022)
• Major Histocompatibility Complex (MHC) Regulation of Autoantibody Responses (Deadline: 30 June 2022)
• Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2021 (Deadline: 30 June 2022)
• Efficacy of Flavonoids in Chronic Diseases (Deadline: 31 July 2022)
• Antibodies in Autoimmune Diseases (Deadline: 31 July 2022)
• Neuroinflammation in the Pathogenesis of Alzheimer's Disease and Related Dementias (Deadline: 31 August 2022)
• Dysfunction in Neurovascular Unit, Neuroinflammation, and the Neurodegenerative Diseases (Deadline: 31 August 2022)
• Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders 2.0 (Deadline: 23 September 2022)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Immunologic and Non-immunologic Mechanisms Leading to Airway Remodeling in Asthma
• Oral Inflammation—Environment, Molecules, and Cells in Oral Physiology and Pathology
• Roles of the Immune System in Cancer
• State-of-the-Art Molecular Immunology in Japan
• Stress, Immunity, and Tissue Microenvironment
• The Adaptive Immunity in COVID-19